Ingevity Q4 Revenue $278M Exceeds Expectations
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 25 2026
0mins
Reports Q4 revenue $278M, consensus $237.8M. "Despite a volatile macro environment, which included tariff uncertainty and supply chain disruptions, Ingevity delivered very strong business and financial results, and our disciplined execution generated robust free cash flow. We also took decisive steps to reshape and optimize our portfolio with the sale of our North Charleston refinery and the majority of our Industrial Specialties product line, as well as the decision to pursue strategic alternatives for Advanced Polymer Technologies and Road Markings. We enter 2026 with momentum and confidence as we continue to drive our strategy to build Ingevity into a premier specialty materials company," said Ingevity President and CEO, David Li.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy NGVT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on NGVT
Wall Street analysts forecast NGVT stock price to fall
3 Analyst Rating
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 73.860
Low
60.00
Averages
67.00
High
71.00
Current: 73.860
Low
60.00
Averages
67.00
High
71.00
About NGVT
Ingevity Corporation develops, manufactures and brings to market solutions that help customers solve complex problems and make the world more sustainable. The Company operates in three reporting segments: Performance Materials, Advanced Polymer Technologies, and Performance Chemicals. The Performance Materials segment manufactures products in the form of powder, granular, extruded pellets, extruded honeycombs, and activated carbon sheets. Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices. Performance chemicals include pavement technologies and road markings. The Company’s products are used in a variety of demanding applications, including automotive gasoline vapor emissions control systems, food, water and chemical filtration, asphalt paving, agrochemical dispersants, bioplastics, coatings, elastomers, and paint for road markings.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Ingevity to Release Q2 2026 Earnings on July 29
- Earnings Release Schedule: Ingevity Corporation will announce its Q2 2026 earnings after market close on July 29, 2026, providing crucial financial data for investor analysis.
- Live Webcast Meeting: The company will host a live webcast on July 30, 2026, at 10:00 a.m. (Eastern) to discuss the fiscal results, enhancing engagement with investors.
- Participation Details: Investors can join the conference call by dialing 833 461 5787 (within the U.S.) or register on the company’s website, ensuring timely communication and transparency.
- Financial Information Access: Following the earnings release, a slide deck containing relevant financial and statistical information will be posted in the investors section, allowing investors to gain deeper insights into the company's financial health and future outlook.
See More
Dentsply Sirona Appoints New CFO John Fortson
- Executive Appointment: Dentsply Sirona has appointed John Fortson as Chief Financial Officer, effective July 20, bringing over 25 years of leadership experience in finance and operations, which is expected to drive the company's financial transformation and growth strategy.
- Extensive Industry Experience: While serving as CFO at Kymera International, Fortson successfully integrated 21 manufacturing facilities and consolidated 12 ERP systems, enhancing operational efficiency, which will provide valuable insights for Dentsply Sirona's financial discipline and growth.
- Strategic Development Plan: Dentsply Sirona's CEO Dan Scavilla noted that Fortson's appointment will strengthen the execution of the company's Return-to-Growth Action Plan, with Fortson's leadership style and strategic mindset expected to support future growth initiatives.
- Long-Term Growth Potential: Fortson expressed that Dentsply Sirona's leading market position and innovative products position the company for long-term growth, and he aims to collaborate with the leadership team to enhance business execution and shareholder value creation.
See More
Dentsply Sirona Appoints New CFO John Fortson to Drive Growth Strategy
- Executive Appointment: Dentsply Sirona has appointed John Fortson as Chief Financial Officer, effective July 20, bringing over 25 years of leadership experience in finance and operations, which will enhance the company's strategic perspective and capital markets expertise.
- Extensive Industry Experience: While serving as CFO at Kymera International, Fortson successfully integrated 21 manufacturing facilities and consolidated 12 ERP systems, significantly improving operational efficiency and financial discipline within the organization.
- Strategic Growth Plan: CEO Dan Scavilla highlighted that Fortson's leadership style and strategic mindset will be instrumental in advancing the company's Return-to-Growth Action Plan, aimed at achieving long-term growth and shareholder value creation.
- Financial Transformation Background: During his tenure at Ingevity Corporation, Fortson implemented a $700 million credit facility and a $300 million high-yield bond offering, strengthening the company's capital structure and demonstrating his capability in financial transformation.
See More
Ingevity to Speak at 2026 Wells Fargo Conference
- Executive Participation: Ingevity's CEO Dave Li and CFO Phillip Platt will participate in the 2026 Wells Fargo 16th Annual Industrials & Materials Conference on June 11, showcasing the company's leadership in the industry.
- Investor Access: The conference will feature a live webcast, allowing investors and interested parties to access the event via a designated link, ensuring transparency and enhancing engagement with stakeholders.
- Company Background: Ingevity is a global specialty materials company focused on developing advanced carbon and engineered material solutions aimed at improving infrastructure longevity and industrial process efficiency, boasting a 90-year legacy of innovation.
- Global Operations: Headquartered in North Charleston, South Carolina, Ingevity operates from 17 locations worldwide and employs approximately 1,400 people, demonstrating its extensive influence and operational capabilities in the global market.
See More
Ingevity (NGVT) Q1 2026 Earnings Transcript
See More
Ingevity Reports Strong Q1 2026 Earnings with Strategic Divestitures
- Sales Growth and Profitability: Ingevity achieved a 4% sales growth in Q1, reaching $258 million, with an EBITDA margin nearing 36%, enabling the company to repurchase approximately $52 million in shares ahead of schedule, thereby enhancing capital return capabilities and market confidence.
- Strategic Asset Sale: The company completed the sale of its Ozark Materials and Road Markings product line for approximately $65 million in cash on April 15, further simplifying its portfolio and reducing earnings volatility, which is expected to lift Performance Chemicals margins to the high teens.
- Future Outlook and Cash Flow: Management reaffirmed guidance for 2026 adjusted EPS to be between $4.70 and $5.20, with sales projected between $1.05 billion and $1.15 billion, and free cash flow expected to reach $215 million to $245 million, indicating strong financial health.
- Inventory and Cost Management: Despite a negative free cash flow of $12 million in Q1 due to seasonality and increased inventory, the company plans to eliminate $15 million in indirect costs associated with the sale of the Industrial Specialties business before the end of Q2, ensuring future profitability.
See More
Ingevity to Release Q2 2026 Earnings on July 29
- Earnings Release Schedule: Ingevity Corporation will announce its Q2 2026 earnings after market close on July 29, 2026, providing crucial financial data for investor analysis.
- Live Webcast Meeting: The company will host a live webcast on July 30, 2026, at 10:00 a.m. (Eastern) to discuss the fiscal results, enhancing engagement with investors.
- Participation Details: Investors can join the conference call by dialing 833 461 5787 (within the U.S.) or register on the company’s website, ensuring timely communication and transparency.
- Financial Information Access: Following the earnings release, a slide deck containing relevant financial and statistical information will be posted in the investors section, allowing investors to gain deeper insights into the company's financial health and future outlook.
See More
Dentsply Sirona Appoints New CFO John Fortson
- Executive Appointment: Dentsply Sirona has appointed John Fortson as Chief Financial Officer, effective July 20, bringing over 25 years of leadership experience in finance and operations, which is expected to drive the company's financial transformation and growth strategy.
- Extensive Industry Experience: While serving as CFO at Kymera International, Fortson successfully integrated 21 manufacturing facilities and consolidated 12 ERP systems, enhancing operational efficiency, which will provide valuable insights for Dentsply Sirona's financial discipline and growth.
- Strategic Development Plan: Dentsply Sirona's CEO Dan Scavilla noted that Fortson's appointment will strengthen the execution of the company's Return-to-Growth Action Plan, with Fortson's leadership style and strategic mindset expected to support future growth initiatives.
- Long-Term Growth Potential: Fortson expressed that Dentsply Sirona's leading market position and innovative products position the company for long-term growth, and he aims to collaborate with the leadership team to enhance business execution and shareholder value creation.
See More
Dentsply Sirona Appoints New CFO John Fortson to Drive Growth Strategy
- Executive Appointment: Dentsply Sirona has appointed John Fortson as Chief Financial Officer, effective July 20, bringing over 25 years of leadership experience in finance and operations, which will enhance the company's strategic perspective and capital markets expertise.
- Extensive Industry Experience: While serving as CFO at Kymera International, Fortson successfully integrated 21 manufacturing facilities and consolidated 12 ERP systems, significantly improving operational efficiency and financial discipline within the organization.
- Strategic Growth Plan: CEO Dan Scavilla highlighted that Fortson's leadership style and strategic mindset will be instrumental in advancing the company's Return-to-Growth Action Plan, aimed at achieving long-term growth and shareholder value creation.
- Financial Transformation Background: During his tenure at Ingevity Corporation, Fortson implemented a $700 million credit facility and a $300 million high-yield bond offering, strengthening the company's capital structure and demonstrating his capability in financial transformation.
See More
Ingevity to Speak at 2026 Wells Fargo Conference
- Executive Participation: Ingevity's CEO Dave Li and CFO Phillip Platt will participate in the 2026 Wells Fargo 16th Annual Industrials & Materials Conference on June 11, showcasing the company's leadership in the industry.
- Investor Access: The conference will feature a live webcast, allowing investors and interested parties to access the event via a designated link, ensuring transparency and enhancing engagement with stakeholders.
- Company Background: Ingevity is a global specialty materials company focused on developing advanced carbon and engineered material solutions aimed at improving infrastructure longevity and industrial process efficiency, boasting a 90-year legacy of innovation.
- Global Operations: Headquartered in North Charleston, South Carolina, Ingevity operates from 17 locations worldwide and employs approximately 1,400 people, demonstrating its extensive influence and operational capabilities in the global market.
See More
Ingevity (NGVT) Q1 2026 Earnings Transcript
See More
Ingevity Reports Strong Q1 2026 Earnings with Strategic Divestitures
- Sales Growth and Profitability: Ingevity achieved a 4% sales growth in Q1, reaching $258 million, with an EBITDA margin nearing 36%, enabling the company to repurchase approximately $52 million in shares ahead of schedule, thereby enhancing capital return capabilities and market confidence.
- Strategic Asset Sale: The company completed the sale of its Ozark Materials and Road Markings product line for approximately $65 million in cash on April 15, further simplifying its portfolio and reducing earnings volatility, which is expected to lift Performance Chemicals margins to the high teens.
- Future Outlook and Cash Flow: Management reaffirmed guidance for 2026 adjusted EPS to be between $4.70 and $5.20, with sales projected between $1.05 billion and $1.15 billion, and free cash flow expected to reach $215 million to $245 million, indicating strong financial health.
- Inventory and Cost Management: Despite a negative free cash flow of $12 million in Q1 due to seasonality and increased inventory, the company plans to eliminate $15 million in indirect costs associated with the sale of the Industrial Specialties business before the end of Q2, ensuring future profitability.
See More
